• BullFrog AI named John Stewart SVP, Commercial Sales to scale revenue for its integrated pharma AI platform.
• Stewart brings 25+ years in enterprise IT sales strategy; most recently held executive roles at Netrix Global, Ricoh USA.
• Eric Roos appointed SVP, Business Development & Corporate Strategy to drive partnerships, pipeline expansion across drug development platforms.
• Roos has 30+ years in biotech; previously Chief Business Development Officer at Aspect Biosystems, Global Strategic Alliances Leader at Thermo Fisher Scientific.
• Tom Hazel named VP, Scientific Operations; he has been VP of Drug Development since 2021, with 20+ years building drug discovery teams.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BullFrog AI Holdings Inc. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.